Covered recipient · General Payments record
ERIN MCFADDEN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2020–2024
$1,461.43
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $683.90 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $195.99 | 6 |
| Acerta Pharma LLC | $181.17 | 4 |
| ABBVIE INC. | $90.96 | 3 |
| Astellas Pharma US Inc | $50.54 | 2 |
| GlaxoSmithKline, LLC. | $35.88 | 2 |
| DEXCOM, INC. | $22.30 | 1 |
| Novo Nordisk AS | $22.21 | 1 |
| ABIOMED | $21.48 | 1 |
| Indivior Inc. | $19.78 | 1 |
| Alkermes, Inc. | $19.31 | 1 |
| Braeburn Inc. | $14.21 | 1 |
| Endogastric Solutions, Inc | $10.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.13 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105001055 | CMS |
| ABBVIE INC. | $29.63 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105001057 | CMS |
| ABBVIE INC. | $33.20 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105001059 | CMS |
| ABIOMED | $21.48 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142309623 | CMS |
| Alkermes, Inc. | $19.31 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120551233 | CMS |
| Amgen Inc. | $14.96 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117323920 | CMS |
| Amgen Inc. | $125.00 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111647798 | CMS |
| Amgen Inc. | $18.76 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117323922 | CMS |
| Amgen Inc. | $9.05 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117323924 | CMS |
| Amgen Inc. | $9.68 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117323926 | CMS |
| Amgen Inc. | $18.54 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117323928 | CMS |
| Astellas Pharma US Inc | $26.75 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139300824 | CMS |
| Astellas Pharma US Inc | $23.79 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139367075 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.65 | 01/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105742478 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.80 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105526791 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.98 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105658738 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.74 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105501702 | CMS |
| Braeburn Inc. | $14.21 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125601313 | CMS |
| Dexcom, Inc. | $22.30 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153299381 | CMS |
| Endogastric Solutions, Inc | $10.07 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144677042 | CMS |
| GlaxoSmithKline, LLC. | $13.92 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116413699 | CMS |
| GlaxoSmithKline, LLC. | $21.96 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115869724 | CMS |
| Indivior Inc. | $19.78 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144533263 | CMS |
| Novo Nordisk Inc | $22.21 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097787425 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.